A Phase 1b Multicenter Open-Label Safety Tolerability and Activity Study of SYNT001 in Subjects with Chronic Stable Warm Autoimmune Hemolytic Anemia (WAIHA)

WAIHA is caused by antibodies (proteins) that attach to red blood cells and causes their destruction. This causes anemia, which means the red blood cell count in the body becomes low. This medical research study is being done to find out more information about the investigational drug SYNT001 for the treatment of WAIHA to find out how well it works and if there are any side effects.

You may be eligible for this study if you meet the following criteria:

• Conditions:
  ['Anemia, Hemolytic, Autoimmune']
• Age: - 99 Years
• Gender: All